Clinical Features of Patients With or Without 18F-FDG Uptake in Aneurysmal Wall
Patient no. | Deciding factor | AAA size (mm) | rSUV | Time between PET and surgery (d) |
No 18F-FDG uptake | ||||
1 | ≥55 mm | 67 | 0.58 | 20 |
2 | ≥55 mm | 70 | 0.33 | 4 |
3 | ≥55 mm | 60 | 0.33 | 5 |
4 | ≥55 mm | 55* | 0.41 | 36 |
5 | ≥55 mm | 57* | 0.18 | 18 |
6 | Growth | 54† | 0.54 | 6 |
7 | ≥55 mm | 80* | 0.76 | 28 |
8 | ≥55 mm | 56 | 0.43 | 8 |
9 | Anxiety | 53 | 0.58 | 26 |
10 | ≥55 mm | 71 | 0.70 | 18 |
Median | 58.5 | 0.49 | 18 | |
IQR | 55.3–69.3 | 0.35–0.58 | 7–25 | |
Positive for 18F-FDG uptake | ||||
11 | Anxiety | 52 | 1.04 | 44 |
12 | Growth | 54 | 0.89 | 7 |
13 | Pain | 40* | 1.93 | 19 |
14 | Growth | 55 | 1.22 | 28 |
15 | ≥55 mm | 69 | 1.06 | 20 |
16 | ≥55 mm | 67 | 0.89 | 5 |
17 | Anxiety | 57 | 0.97 | 21 |
18‡ | Growth | 53 | 0.84 | 11 |
Median | 54.5 | 1.00§ | 19 | |
IQR | 52.8–59.5 | 0.89–1.10 | 10–23 |